XBKK
SKR
Market cap496mUSD
Nov 12, Last price
7.70THB
Name
Sikarin PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sikarin Public Company Limited, together with its subsidiaries, operates hospitals in Thailand. It operates diabetes and endocrine center, general medicine clinic, orthopedic center, emergency and trauma center, surgery clinic, children center, dental center, aesthetic center, laboratory department, diagnostic radiology center, CT scan unit, operating rooms, hemodialysis unit, physical therapy department with physical medicine and rehabilitation specialist, catheter laboratory, intensive care units, coronary care unit, inpatient wards and international wards, after heart and thoracic surgery ward, medical ward, and pediatric ward. The company also operates woman's health center, health center, fertility center, delivery room, nursery department and the inpatient wards, obstetrics and gynecology ward, gastroenterology and scope center, neurology center, stroke center, EENT center, international medical center, and MRI center. It is also involved in the management of rental spaces; and sale of food and beverages. The company's hospitals comprise Sikarin Hospital with 355 beds in Bangkok; Rattarin Hospital with 100 beds in Muang; and Sikarin Hat-Yai Hospital with 350 beds in Hat Yai. Sikarin Public Company Limited was founded in 1979 and is headquartered in Bangkok, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||